鼻型弥漫大B细胞淋巴瘤合并肺腺癌1例并文献复习

doi:10.6040/j.issn.1671-7554.0.2023.0346

摘要/Abstract

中图分类号:

R593.2

杜圣红,李晓梅,陈晨,王玲. 鼻型弥漫大B细胞淋巴瘤合并肺腺癌1例并文献复习[J]. 山东大学学报 (医学版), 2023, 61(8): 111-115.

[1] Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of non-hodgkins lymphoma[J]. Med Sci(Basel), 2021, 9(1): 5. doi: 10.3390/medsci9010005.
[2] Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era[J]. Blood, 2021, 137(1):39-48.
[3] Shi Y, Han Y, Yang J, et al. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: analysis of 1,085 WHO classified cases in a single institution in China[J]. Chin J Cancer Res, 2019, 31(1):152-161.
[4] Chen Y, Wang X, Li L, et al. Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI[J]. Neuroradiology, 2020, 62(9):1149-1155.
[5] 孙文文, 张燕林, 杨开颜,等. 鼻腔鼻咽部淋巴瘤:319例会诊病例分析[J]. 临床与实验病理学杂志, 2017, 33(11):1194-1198.
[6] 刘丁丁, 钱晓云, 刘永泽, 等. 84例原发头颈部淋巴瘤临床及病理特征分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(6):48-51. LIU Dingding, QIAN Xiaoyun, LIU Yongze, et al. Analysis of clinical and pathological features of 84 patients with primary head and neck lymphoma [J]. Journal of Otolaryngology and ophthalmology Shandong University, 2018, 32(6):48-51.
[7] 秦贺,胡斌, 叶京英. 鼻和咽部原发性非霍奇金淋巴瘤17例临床分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(4):51-53. QIN He, HU Bin, YE Jingying. Clinical analysis of 17 patients with primary non-Hodgkin lymphoma in the nose and the pharynx [J]. Journal of Otolaryngology and Ophthalmology Shandong University, 2017, 31(4):51-53.
[8] Varelas AN, Eggerstedt M, Ganti A, et al. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B-cell lymphoma[J]. Laryngoscope, 2019, 129(6):1259-1264.
[9] Huang Y, Jia B, Jiang S, et al. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma[J]. J Hematol Oncol, 2017, 10(1):7. doi: 10.1186/s13045-016-0368-9.
[10] Eriksen PRG, Clasen-Linde E, Nully Brown P, et al. Sinonasal b-cell lymphomas: a nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma[J]. Hematol Oncol, 2022, 40(2):160-171.
[11] Xie M, Zhang Q, Guo R, et al. [Clinical features of diffuse large B-cell lymphoma in head and neck] [J]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2022, 36(1):1-7.
[12] Jin K, Wang K, Zhang H, et al. Solitary pulmonary lesion in patients with history of malignancy: primary lung cancer or metastatic cancer?[J]. Ann Surg Oncol, 2018, 25(5):1237-1244.
[13] Epstein SS,Shaw HJ. Multiple malignant neoplasms in the air and upper food passages[J]. Cancer, 1958, 11(2):326-333.
[14] Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours: challenges and approaches, a review[J]. ESMO Open, 2017, 2(2):e000172. doi: 10.1136/esmoopen-2017-000172.
[15] Jiang Y, Miao Z, Wang J, et al. Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients[J]. Tumori, 2019, 105(6):474-482.
[16] 李丹妮,汪劭婷. 肺癌、淋巴瘤组成的多原发癌24例临床分析[J]. 癌症进展, 2019, 17(19):2273-2275. LI Danni, WANG Shaoting. Clinical analyses of 24 patients with mutiple primary cancer of lung cancer and lymphoma [J]. Oncology progress, 2019, 17(19):2273-2275.
[17] Zheng Y, Sun Y, Kuai Y, et al. Gene expression profiling for the diagnosis of multiple primary malignant tumors[J]. Cancer Cell Int, 2021, 21(1):47. doi: 10.1186/s12935-021-01748-8.
[18] Batra U, Biswas B, Prabhash K, et al. Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer[J]. BMJ Open Respir Res, 2023, 10(1). doi: 10.1136/bmjresp-2022-001492.

相关文章 15

[1]	孟健丽,王庆港. 生物信息学方法探讨VPS72在肺腺/鳞癌中的表达及潜在作用机制[J]. 山东大学学报 (医学版), 2023, 61(8): 40-49.
[2]	刘士标,张淑君,李培龙,杜鲁涛,王传新. cg20657709位点甲基化对肺腺癌早期诊断的初步探讨[J]. 山东大学学报 (医学版), 2023, 61(4): 18-25.
[3]	洪慧,张卫海,李惠娴,李伟伟,张金岭. 异时性阑尾印戒细胞癌合并肺腺癌双原发癌1例[J]. 山东大学学报 (医学版), 2022, 60(8): 130-132.
[4]	郑昊天,王光辉,赵小刚,王亚东,曾榆凯,杜贾军. 基于数据库LKB1突变肺腺癌DNA异常甲基化位点构建的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(3): 51-58.
[5]	庞兆飞,柳勇,赵小刚,闫涛,陈效伟,杜贾军. 基于公共数据库构建肺腺癌肿瘤干性评分模型预测免疫治疗疗效[J]. 山东大学学报 (医学版), 2021, 59(11): 19-28.
[6]	柴小雪,叶辉,吕欣然,丁续超,甄秋来,杜娟,曹莉莉. POU4F3表达对118例肺腺癌患者预后评估及对肺腺癌细胞株迁移的影响[J]. 山东大学学报 (医学版), 2021, 59(11): 8-18.
[7]	杨秀婷,刘启功,左萍,刘正湘,左后娟. CD151-MUT突变对肺腺癌细胞A549迁移的影响及机制[J]. 山东大学学报 (医学版), 2020, 58(3): 81-86.
[8]	郑清月,赵秋红,渠香云,董肇楠,马雪情,贾云莉. 血清外泌体miR-205-5p/miR-152-5p对早期非小细胞肺癌的诊断价值[J]. 山东大学学报 (医学版), 2019, 57(10): 101-106.
[9]	谢厚耐,李猛,许林,王晖,彭岳,彭忠民. 吉非替尼对比培美曲塞联合顺铂治疗术后EGFR突变阳性Ⅱ~ⅢA期肺腺癌的临床分析[J]. 山东大学学报 (医学版), 2018, 56(9): 29-34.
[10]	张智慧,王丽丽,高华,张健,李娟,李远,武春晓,卢志明. 肺腺癌中缺氧诱导因子-1α调控程序性死亡因子配体1的表达[J]. 山东大学学报（医学版）, 2017, 55(4): 65-70.
[11]	唐曦,胡娅,徐炎华,汪春林,邱萍,王向辉. MiR- 498通过下调FOXM1抑制肺腺癌细胞上皮充质细胞转化[J]. 山东大学学报（医学版）, 2017, 55(4): 39-43.
[12]	李学玲, 董西林, 岳英. 二甲双胍抑制裸鼠肺腺癌移植瘤生长的实验研究[J]. 山东大学学报（医学版）, 2014, 52(S1): 1-2.
[13]	孙杰，牟晓燕，董雪丽. 舒尼替尼与吉西他滨联合及序贯应用对K-RAS突变A549细胞的影响[J]. 山东大学学报（医学版）, 2014, 52(3): 45-49.
[14]	董雪丽，牟晓燕，刘庆亮，孙杰. 塞来昔布联合厄罗替尼对人肺癌裸鼠移植瘤生长及血管生成的影响[J]. 山东大学学报(医学版), 2013, 51(2): 49-52.
[15]	范恒建，张玉可，肖伟，张一，李海军，王得翔 . 肺腺癌患者外周血Treg和Th17细胞的变化及其对预后的影响[J]. 山东大学学报(医学版), 2012, 50(9): 73-78.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed